Clinical Trials
4 trialsNCT03161834 2021-05-21
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Withdrawn
NCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT03096899 2018-08-31
A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma
The Rogosin Institute
Withdrawn
NCT00796874 2013-07-25
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
Roswell Park Cancer Institute
Phase NA Withdrawn